Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Interesting read on the backlash to FDA's approval of aducanumab

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Interesting read on the backlash to FDA's approval of aducanumab

golfyeti

Jun 10, 2021 07:59PM

Re: Interesting read on the backlash to FDA's approval of aducanumab

tada

Jun 10, 2021 08:35PM

tada

Rank: President [?]

Points: 7691 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Interesting read on the backlash to FDA's approval of aducanumab

in response to

Re: Interesting read on the backlash to FDA's approval of aducanumab

tada

posted on Jun 10, 2021 08:47PM

Follow-up to the last post. The increase in the share price of BIIB is very telling that the world really wants a drug that will help ease the burden of Alzheimer's. With BIIB going up $16 billion on this news, the cardio market potentially worth $10 billion for ABL and a positive COVID trial potentially giving us a $4 billion market for that therapy, we could potentially be sitting on a $30 billion market cap company. In reality though it sometimes seems like it's just a pile of dung.

tada

4 Recommendations

Re: Interesting read on the backlash to FDA's approval of aducanumab

KOO-KOO2

Jun 11, 2021 06:46AM

Re: Interesting read on the backlash to FDA's approval of aducanumab

golfyeti

Jun 11, 2021 10:23AM

Re: Interesting read on the backlash to FDA's approval of aducanumab

tada

Jun 11, 2021 11:32AM

Re: Interesting read on the backlash to FDA's approval of aducanumab